NEXPOINT ASSET MANAGEMENT, L.P.

Position in APGE — Apogee Therapeutics, Inc.

CIK 1469877 Dallas, TX

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$39,811,035

New position

Shares Held

299,940

first reported quarter

Ownership

0.396%

of shares outstanding

% of Portfolio

3.41%

of 13F equity value

Holder Rank

#47

of 285 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NEXPOINT ASSET MANAGEMENT, L.P. holds $42,033,442 across 5 Biotechnology names. APGE ranks #1 (94.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc. This page	299,940	$39,811,035
2	RNA	Atrium Therapeutics, Inc.	150,025	$2,017,835
3	HRTX	Heron Therapeutics, Inc. /De/	475,750	$204,572
4			1,602,557	$0
5			617,820	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$39,811,035	299,940	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.